APOE and Alzheimer disease: The TYROBP receptor that has received the most attention in the AD field is TREM2 because of the discovery in 2013 that patients harboring the TREM2R47H variant are at increased relative risk for developing AD similar to that associated with the APOE*ε4 allele [97, 98].